TY - JOUR AU - Dombrovskiy, V. Y. AU - Martin, A. A. AU - Sunderram, J. AU - Paz, H. L. PY - 2007 DA - 2007// TI - Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003 JO - Crit Care Med VL - 35 UR - https://doi.org/10.1097/01.CCM.0000261890.41311.E9 DO - 10.1097/01.CCM.0000261890.41311.E9 ID - Dombrovskiy2007 ER - TY - JOUR AU - Dellinger, R. P. AU - Levy, M. M. AU - Carlet, J. M. AU - Bion, J. AU - Parker, M. M. AU - Jaeschke, R. AU - Reinhart, K. AU - Angus, D. C. AU - Brun-Buisson, C. AU - Beale, R. AU - Calandra, T. AU - Dhainaut, J. -. F. AU - Gerlach, H. AU - Harvey, M. AU - Marini, J. J. AU - Marshall, J. AU - Ranieri, M. AU - Ramsay, G. AU - Sevransky, J. AU - Thompson, B. T. AU - Townsend, S. AU - Vender, J. S. AU - Zimmerman, J. L. AU - Vincent, J. L. PY - 2008 DA - 2008// TI - Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 JO - Crit Care Med VL - 36 UR - https://doi.org/10.1097/01.CCM.0000298158.12101.41 DO - 10.1097/01.CCM.0000298158.12101.41 ID - Dellinger2008 ER - TY - JOUR AU - Sharma, V. K. AU - Dellinger, R. P. PY - 2006 DA - 2006// TI - Treatment options for severe sepsis and septic shock JO - Expert Rev Anti Infect Ther VL - 4 UR - https://doi.org/10.1586/14787210.4.3.395 DO - 10.1586/14787210.4.3.395 ID - Sharma2006 ER - TY - JOUR AU - Nawroth, P. P. AU - Bank, I. AU - Handley, D. AU - Cassimeris, J. AU - Chess, L. AU - Stern, D. PY - 1986 DA - 1986// TI - Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 JO - J Exp Med VL - 163 UR - https://doi.org/10.1084/jem.163.6.1363 DO - 10.1084/jem.163.6.1363 ID - Nawroth1986 ER - TY - JOUR AU - Spooner, C. E. AU - Markowitz, N. P. AU - Saravolatz, L. D. PY - 1992 DA - 1992// TI - The role of tumor necrosis factor in sepsis JO - Clin Immunol Immunopathol VL - 62 UR - https://doi.org/10.1016/0090-1229(92)90036-N DO - 10.1016/0090-1229(92)90036-N ID - Spooner1992 ER - TY - JOUR AU - van der Poll, T. AU - van Deventer, S. J. PY - 1999 DA - 1999// TI - Cytokines and anticytokines in the pathogenesis of sepsis JO - Infect Dis Clin North Am VL - 13 UR - https://doi.org/10.1016/S0891-5520(05)70083-0 DO - 10.1016/S0891-5520(05)70083-0 ID - van der Poll1999 ER - TY - JOUR AU - Thijs, L. G. AU - Hack, C. E. PY - 1995 DA - 1995// TI - Time course of cytokine levels in sepsis JO - Intensive Care Med VL - 21 UR - https://doi.org/10.1007/BF01740764 DO - 10.1007/BF01740764 ID - Thijs1995 ER - TY - JOUR AU - Antonopoulou, A. AU - Giamarellos-Bourboulis, E. J. PY - 2011 DA - 2011// TI - Immunomodulation in sepsis: state of the art and future perspective JO - Immunotherapy VL - 3 UR - https://doi.org/10.2217/imt.10.82 DO - 10.2217/imt.10.82 ID - Antonopoulou2011 ER - TY - JOUR AU - Qiu, P. AU - Cui, X. AU - Barochia, A. AU - Li, Y. AU - Natanson, C. AU - Eichacker, P. Q. PY - 2011 DA - 2011// TI - The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death JO - Expert Opin Investig Drugs VL - 20 UR - https://doi.org/10.1517/13543784.2011.623125 DO - 10.1517/13543784.2011.623125 ID - Qiu2011 ER - TY - JOUR AU - Nelson, P. N. AU - Reynolds, G. M. AU - Waldron, E. E. AU - Ward, E. AU - Giannopoulos, K. AU - Murray, P. G. PY - 2000 DA - 2000// TI - Monoclonal antibodies JO - Mol Pathol VL - 53 UR - https://doi.org/10.1136/mp.53.3.111 DO - 10.1136/mp.53.3.111 ID - Nelson2000 ER - TY - JOUR AU - Covell, D. G. AU - Barbet, J. AU - Holton, O. D. AU - Black, C. D. AU - Parker, R. J. AU - Weinstein, J. N. PY - 1986 DA - 1986// TI - Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice JO - Cancer Res VL - 46 ID - Covell1986 ER - TY - JOUR AU - Schaumann, W. AU - Kaufmann, B. AU - Neubert, P. AU - Smolarz, A. PY - 1986 DA - 1986// TI - Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication JO - Eur J Clin Pharmacol VL - 30 UR - https://doi.org/10.1007/BF00542410 DO - 10.1007/BF00542410 ID - Schaumann1986 ER - TY - JOUR AU - Rice, T. W. AU - Wheeler, A. P. AU - Morris, P. E. AU - Paz, H. L. AU - Russell, J. A. AU - Edens, T. R. AU - Bernard, G. R. PY - 2006 DA - 2006// TI - Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000230385.82679.34 DO - 10.1097/01.CCM.0000230385.82679.34 ID - Rice2006 ER - TY - CHAP AU - Newham, P. AU - Heier, A. AU - Brennan, F. AU - Ceuppens, P. AU - Growcott, J. PY - 2011 DA - 2011// TI - AZD9773 is a novel selective anti-TNF-α ovine polyclonal immune Fab BT - Clin Microbiol Infect (Suppl) ID - Newham2011 ER - TY - JOUR AU - Newham, P. AU - Yates, J. W. T. AU - Das, S. AU - Kemp, J. AU - Ceuppens, P. AU - Brennan, F. AU - Knight, R. AU - Growcott, J. PY - 2011 DA - 2011// TI - Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNF-α polyclonal immune ovine Fab similar to D-CytoFab JO - Crit Care Med VL - 15 ID - Newham2011 ER - TY - CHAP PY - 2011 DA - 2011// BT - Quantikine®. Human TNF-α Immunoassay. For the quantitative determination of human tumor necrosis factor alpha (TNF-alpha) concentrations in cell culture supernates, serum, and plasma ID - ref16 ER - TY - CHAP PY - 2011 DA - 2011// BT - Quantikine® ELISA. Human IL-6 Immunoassay. For the quantitative determination of human interleukin 6 (IL-6) concentrations in cell culture supernates, serum, and plasma ID - ref17 ER - TY - STD TI - Brahms Diagnostic. Procalcitonin assays. 2011. [http://www.procalcitonin.com/default.aspx?tree=_0] UR - http://www.procalcitonin.com/default.aspx?tree=_0 ID - ref18 ER - TY - JOUR AU - Vincent, J. L. AU - Moreno, R. AU - Takala, J. AU - Willatts, S. AU - de Mendonça, A. AU - Bruining, H. AU - Reinhart, C. K. AU - Suter, P. M. AU - Thijs, L. G. PY - 1996 DA - 1996// TI - The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine JO - Intensive Care Med VL - 22 UR - https://doi.org/10.1007/BF01709751 DO - 10.1007/BF01709751 ID - Vincent1996 ER - TY - CHAP PY - 2007 DA - 2007// BT - Guideline on Immunogenicity Assessment of Biotechnology-Derived Therapeutic Proteins ID - ref20 ER - TY - JOUR AU - Mire-Sluis, A. R. AU - Barrett, Y. C. AU - Devanarayan, V. AU - Koren, E. AU - Liu, H. AU - Maia, M. AU - Parish, T. AU - Scott, G. AU - Shankar, G. AU - Shores, E. AU - Swanson, S. J. AU - Taniguchi, G. AU - Wierda, D. AU - Zuckerman, L. A. PY - 2004 DA - 2004// TI - Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products JO - J Immunol Methods VL - 289 UR - https://doi.org/10.1016/j.jim.2004.06.002 DO - 10.1016/j.jim.2004.06.002 ID - Mire-Sluis2004 ER - TY - JOUR AU - Shankar, G. AU - Devanarayan, V. AU - Amaravadi, L. AU - Barrett, Y. C. AU - Bowsher, R. AU - Finco-Kent, D. AU - Fiscella, M. AU - Gorovits, B. AU - Kirschner, S. AU - Moxness, M. AU - Parish, T. AU - Quarmby, V. AU - Smith, H. AU - Smith, W. AU - Zuckerman, L. A. AU - Koren, E. PY - 2008 DA - 2008// TI - Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products JO - J Pharm Biomed Anal VL - 48 UR - https://doi.org/10.1016/j.jpba.2008.09.020 DO - 10.1016/j.jpba.2008.09.020 ID - Shankar2008 ER - TY - CHAP AU - Yates, J. W. AU - Das, S. AU - Mainwaring, G. AU - Kemp, J. PY - 2011 DA - 2011// TI - Population PK/PD modelling AZD9773 in patients with severe sepsis. 20th meeting of the Population Approach Group in Europe BT - Athens, Greece ID - Yates2011 ER - TY - JOUR AU - Newham, P. AU - Snow, M. AU - Eckersley, S. AU - Davies, G. AU - Abbott, M. PY - 2011 DA - 2011// TI - AZD9773, a novel anti-tumor necrosis factor-a immune Fab in development for severe sepsis and septic shock: analyses of complex formation and binding sites with TNF-α JO - Crit Care Med VL - 39 ID - Newham2011 ER - TY - JOUR AU - Hwang, W. Y. AU - Foote, J. PY - 2005 DA - 2005// TI - Immunogenicity of engineered antibodies JO - Methods VL - 36 UR - https://doi.org/10.1016/j.ymeth.2005.01.001 DO - 10.1016/j.ymeth.2005.01.001 ID - Hwang2005 ER - TY - CHAP PY - 2010 DA - 2010// BT - CroFab (Crotalidae Polyvalent Immune Fab) Prescribing Information ID - ref26 ER - TY - CHAP PY - 2010 DA - 2010// BT - Digibind (Digoxin Immune Fab) Summary of Product Characteristics ID - ref27 ER -